Wire Stories
BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT� (Siltuximab for Injection) in China for Idiopathic Multicentric Castleman Disease
CAMBRIDGE, Mass. & BEIJING & HEMEL HEMPSTEAD, England–(BUSINESS WIRE)–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160) and EUSA Pharma (UK), Ltd. today announced that...